Thermo Fisher Scientific Inc.
TMO · Healthcare · Life Sciences Tools & Services
Updated 27 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #44 of 500 by Iconic Score · #6 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Thermo Fisher Scientific Inc. (TMO) is a leading provider of life sciences tools and services, specializing in analytical instruments, reagents, consumables, and software solutions that support scientific research and healthcare applications. With a market capitalization of $193.8 billion, the company holds a strong position in the healthcare sector, serving a diverse clientele that includes pharmaceutical and biotech companies, academic institutions, and hospitals. Thermo Fisher's extensive portfolio enables advancements in areas such as drug development, diagnostics, and environmental monitoring, making it a critical player in the life sciences ecosystem. Its commitment to innovation and quality positions it as a trusted partner in addressing global health challenges and driving scientific discovery, underscoring its significance in the ongoing evolution of healthcare and research methodologies.
IconicOracleAI™ Brief
Thermo Fisher Scientific Inc. currently holds an Iconic Score of 67, reflecting strong brand visibility with a score of 85/100 from logo analysis. Recent headlines indicate a mixed sentiment, as the company reported solid third-quarter results, yet the broader healthcare sector experienced declines, impacting investor perception. Additionally, discussions around tariff refunds have influenced market reactions, contributing to a nuanced view of the company's financial performance.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.